SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Galectin Therapeutics Inc. To Contact Brower Piven Before The September 29, 2014 Lead Plaintiff Deadline In Class 